Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01876641
Title Treatment of a Resistant Disease Using Decitabine Combined With Vemurafenib
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors University of Iowa
Indications

melanoma

Therapies

Decitabine + Vemurafenib

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST